NovaBridge Biosciences CMO Dennis Phillip Andrew sells 8,209 shares for $5,827.39
NBP•Insider share sale follows RSU settlement
- NovaBridge Biosciences Chief Medical Officer Dennis Phillip Andrew reported an RSU settlement into 23,695 ordinary shares on Sep. 17.
- He sold 8,209 ordinary shares on Sep. 18 at USD 0.71 per share.
- Directly owned ordinary shares ended at 173,427 following the transactions.
- Directly held restricted share units stood at 72,120 after the Sep. 17 vesting.
